Virtual Screening of FDA-Approved Drugs on Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) to Obtain New Trypanocidal Agents
Seven FDA-approved drugs are candidates for further studies leading to the development of potential new treatments for Chagas disease.
Authors
- Lenci K. Vázquez‐Jiménez (ORCID: https://orcid.org/0000-0002-9327-9658)
- Rogelio Gómez-Escobedo
- Eyra Ortíz-Pérez (ORCID: https://orcid.org/0000-0003-3800-0228)
- Benjamín Nogueda‐Torres
Institutions
- Instituto Politécnico Nacional (MX)
- Autonomous University of Tamaulipas (MX)
Publication Details
- Journal
- Medicinal Chemistry
- Published
- 2025-10-22
- DOI
- https://doi.org/10.2174/0115734064408199251003102853
- Primary Topic
- Trypanosoma species research and implications
- Type
- article
- Field-Weighted Citation Impact
- 0.00